BLADDER CANCER PD-L1 and BCG response prediction

被引：7
|
作者：
Thoma, Clemens
机构：
[1] Nature Reviews Urology,
来源：
NATURE REVIEWS UROLOGY | 2020年 / 17卷 / 01期
关键词：
D O I：
10.1038/s41585-019-0267-2
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：8 / 8
页数：1
相关论文
共 50 条
  • [21] Anti-PD-1 and PD-L1 therapy for bladder cancer: what is on the horizon?
    Sundararajan, Srinath
    Vogelzang, Nicholas J.
    FUTURE ONCOLOGY, 2015, 11 (16) : 2299 - 2306
  • [22] PD-L1 Expression in Nonbacterial Chronic Cystitis and Bladder Cancer
    Kosova, Inga
    Barsegian, Vagan
    Gundorova, Lyudmila
    Kolbasov, Dmitriy
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2024, 35 (05) : 1069 - 1075
  • [23] Prognostic importance of PD-L1 expression in bladder cancer patients
    Durur, Sumeyye
    Uzun, Hakki
    Bedir, Recep
    Nalkiran, Ihsan
    Nalkiran, Hatice Sevim
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (SUPPL 2) : S633 - S638
  • [24] Prognostic importance of PD-L1 expression in bladder cancer patients
    Durur, Sumeyye
    Uzun, Hakki
    Bedir, Recep
    Nalkiran, Ihsan
    Nalkiran, Hatice Sevim
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 : S633 - S638
  • [25] PD-L1 Immunotherapy shrinks tumors in Bladder Cancer Patients
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (09) : 2120 - 2120
  • [26] Genentech's PD-L1 agent approved for bladder cancer
    Mark Ratner
    Nature Biotechnology, 2016, 34 : 789 - 790
  • [27] Genentech's PD-L1 agent approved for bladder cancer
    Ratner, Mark
    NATURE BIOTECHNOLOGY, 2016, 34 (08) : 789 - 790
  • [28] Comparison the results from PD-L1 IHC and PD-L1 multiplex immunofluorescence for the prediction of anti-PD-1 immunotherapeutic response
    Sun, Hongzhe
    Liu, Xia
    Jiao, Tao
    Guo, Qian
    Du, Haizhen
    Han, Shuo
    Zhu, Lin
    Zhang, Zhifu
    Kong, Yan
    Li, Na
    CANCER RESEARCH, 2024, 84 (06)
  • [29] Comparison of PD-L1 Immunohistochemistry Assays and Response to PD-L1 Inhibitors
    Dacic, S.
    Ancevski, K.
    Aberrbock, S.
    Herbst, C.
    Villaruz, L.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2115 - S2115
  • [30] PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG responders
    Pierconti, F.
    Rosaria, Raspollini Maria
    Martini, Maurizio
    Larocca, Luigi Maria
    Bassi, P. F.
    Bientinesi, R.
    Gianna, Baroni
    Andrea, Minervini
    Petracco, G.
    Pini, G. M.
    Patriarca, C.
    VIRCHOWS ARCHIV, 2020, 477 (02) : 269 - 277
12345